The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IWWM-11 2022 | Molecular clusters and tumor-immune drivers of IgM monoclonal gammopathies
Patrizia Mondello, MD, PhD, Mayo Clinic, Rochester, MN, shares some findings from a study which used next-generation sequencing (NGS) techniques and a multi-omics approach to evaluate various clusters of IgM monoclonal gammopathies. Dr Mondello highlights three distinct molecular clusters that were identified, and the implications of these findings in the treatment of Waldenström’s macroglobulinemia (WM). This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
